Skip to main content
NVO
NYSE Life Sciences

Novo Nordisk Inks $1.4B AI Drug Discovery Deal with Orbis Medicine

Tom Rudovsky · Reported by Seeking Alpha
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$41.87
Mkt Cap
$184.764B
52W Low
$35.12
52W High
$64.16
52W Position info
19% above low
Off High info
35% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

NVO sits 19% above its 52-week low of $35.12.

Summary

Novo Nordisk announced a drug discovery partnership with Orbis Medicine worth up to $1.4B, including a strategic investment in the Copenhagen-based biotech. The collaboration leverages Orbis's AI-led nGen platform to develop oral macrocycle treatments for cardiometabolic diseases. Orbis will receive upfront and milestone payments plus tiered royalties. This expands Novo's cardiometabolic pipeline beyond its GLP-1 franchise and follows recent pipeline setbacks like the ZEUS trial failure. The deal is modest relative to Novo's market cap but signals continued investment in next-generation oral therapies.

At the time of this announcement, NVO was trading at $41.87 on NYSE in the Life Sciences sector, with a market capitalization of approximately $184.8B. The 52-week trading range was $35.12 to $64.16. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Seeking Alpha.


Price Chart

Share this article

Copied!

NVO - Latest Insights

NVO
Nov 04, 2026, 8:35 AM EST
Source: Benzinga
Importance Score:
8
Price at Filing: $42.91
Real-time Price: $39.57 info
Change: -$3.34 (-8%) info
Market Cap: $179.28B info
NVO
Nov 04, 2026, 7:47 AM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $42.90
Real-time Price: $39.57 info
Change: -$3.33 (-8%) info
Market Cap: $179.28B info
NVO
Nov 04, 2026, 4:00 AM EST
Source: Seeking Alpha
Importance Score:
9
Price at Filing: $41.96
Real-time Price: $39.57 info
Change: -$2.39 (-6%) info
Market Cap: $179.28B info
NVO
Oct 27, 2026, 3:10 AM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $39.16
Real-time Price: $39.57 info
Change: +$0.410 (+1%) info
Market Cap: $179.28B info
NVO
Oct 02, 2026, 5:53 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $36.88
Real-time Price: $39.57 info
Change: +$2.69 (+7%) info
Market Cap: $179.28B info